Tang, Mimi
Zhou, Qian
Huang, Mengqi
Sun, Kaiyu
Wu, Tingfan
Li, Xin
Liao, Bing
Chen, Lili
Liao, Junbin
Peng, Sui
Chen, Shuling
Feng, Shi-Ting http://orcid.org/0000-0002-0869-7290
Funding for this research was provided by:
the National Natural Science Foundation of China (81971684, 81801703)
the National Natural Science Foundation of China (81771908)
the Guangdong Natural Science Foundation of Guangdong Province (2018A030310282)
Article History
Received: 16 October 2020
Revised: 18 February 2021
Accepted: 25 March 2021
First Online: 20 April 2021
Declarations
:
: The scientific guarantor of this publication is Shi-Ting Feng.
: Two of the authors (Tingfan Wu, Xin Li) are employees of GE Healthcare. The remaining authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Two hundred and seven study subjects have been previously reported in “Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging” which has been published in <i>European Radiology</i>. This study is different from the previous one either in the objective or in the method.
: • Retrospective• Diagnostic or prognostic study• Performed at one institution